Literature DB >> 1702760

Properties of a rat monoclonal antibody reactive with both the mannan of Candida species and the O-antigen 6,7 polysaccharide of serogroup C1 salmonellae.

N A Nnalue1, A Weintraub, A A Lindberg.   

Abstract

Monoclonal antibody MASC1-MR9 of isotype immunoglobulin M was generated in LOU/C rats by immunization with heat-killed Salmonella thompson (serogroup C1, O-antigen 6,7 lipopolysaccharide) bacteria which had been further enriched for O-antigen by coating with homologous lipopolysaccharide. Eight monoclonal antibodies were selected by screening against the lipopolysaccharide of S. thompson. In a subsequent test against Candida mannan, only one antibody, MASC1-MR9, was reactive. Immunofluorescence microscopy of various yeasts and bacteria with MASC1-MR9 showed that this antibody bound to the surfaces of 142 of 148 Candida strains of 10 different species tested but failed to bind to the surface of Saccharomyces cerevisiae. The Candida strains which failed to bind MASC1-MR9 were all five strains of Candida krusei and the single strain of Candida utilis tested. Several (11 of 33) Salmonella strains belonging to serogroup C1 reacted with this antibody, as expected; however, 1 of 11 strains of Morganella morganii and 4 of 64 strains of Escherichia coli were also reactive. Serum-free supernatants of MASC1-MR9 agglutinated S. thompson, one strain of Salmonella choleraesuis, and 109 of 110 Candida strains tested. The immunochemical properties of MASC1-MR9 as studied by enzyme-linked immunosorbent inhibition assays show that it recognizes an epitope present in the mannan of Candida species as well as in the O-6,7 antigen of Salmonella species.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1702760      PMCID: PMC257731          DOI: 10.1128/iai.59.1.229-233.1991

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  29 in total

1.  POLYSACCHARIDE ANTIGENS OF CANDIDA CELL WALL.

Authors:  D F SUMMERS; A P GROLLMAN; H F HASENCLEVER
Journal:  J Immunol       Date:  1964-03       Impact factor: 5.422

2.  Production and characterisation of a monoclonal antibody to a cell-surface, glucomannoprotein constituent of Candida albicans and other pathogenic Candida species.

Authors:  A Cassone; A Torosantucci; M Boccanera; G Pellegrini; C Palma; F Malavasi
Journal:  J Med Microbiol       Date:  1988-12       Impact factor: 2.472

3.  Candida precipitins.

Authors:  W H Chew; T L Theus
Journal:  J Immunol       Date:  1967-02       Impact factor: 5.422

4.  Oral Candida albicans isolates from nonhospitalized normal carriers, immunocompetent hospitalized patients, and immunocompromised patients with or without acquired immunodeficiency syndrome.

Authors:  D L Brawner; J E Cutler
Journal:  J Clin Microbiol       Date:  1989-06       Impact factor: 5.948

5.  Catheter-associated Candida utilis fungemia in a patient with acquired immunodeficiency syndrome: species verification with a molecular probe.

Authors:  A Alsina; M Mason; R A Uphoff; W S Riggsby; J M Becker; D Murphy
Journal:  J Clin Microbiol       Date:  1988-04       Impact factor: 5.948

6.  Systemic candidiasis in cancer patients.

Authors:  A W Maksymiuk; S Thongprasert; R Hopfer; M Luna; V Fainstein; G P Bodey
Journal:  Am J Med       Date:  1984-10-30       Impact factor: 4.965

7.  Preparation of monoclonal antibodies reactive with beta-1,2-linked oligomannosyl residues in the phosphomannan-protein complex of Candida albicans NIH B-792 strain.

Authors:  M Tojo; N Shibata; M Kobayashi; T Mikami; M Suzuki; S Suzuki
Journal:  Clin Chem       Date:  1988-03       Impact factor: 8.327

8.  Prevalence of cutaneous disease in patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related complex.

Authors:  D S Goodman; E D Teplitz; A Wishner; R S Klein; P G Burk; E Hershenbaum
Journal:  J Am Acad Dermatol       Date:  1987-08       Impact factor: 11.527

9.  Clinical, microbiological, and experimental animal studies of Candida lipolytica.

Authors:  T J Walsh; I F Salkin; D M Dixon; N J Hurd
Journal:  J Clin Microbiol       Date:  1989-05       Impact factor: 5.948

Review 10.  Emergence of a new opportunistic pathogen, Candida lusitaniae.

Authors:  R J Blinkhorn; D Adelstein; P J Spagnuolo
Journal:  J Clin Microbiol       Date:  1989-02       Impact factor: 5.948

View more
  2 in total

1.  Specific antibody response to oligomannosidic epitopes in Crohn's disease.

Authors:  B Sendid; J F Colombel; P M Jacquinot; C Faille; J Fruit; A Cortot; D Lucidarme; D Camus; D Poulain
Journal:  Clin Diagn Lab Immunol       Date:  1996-03

2.  Structures of cell wall mannans of pathogenic Candida tropicalis IFO 0199 and IFO 1647 yeast strains.

Authors:  H Kobayashi; K Matsuda; T Ikeda; M Suzuki; S Takahashi; A Suzuki; N Shibata; S Suzuki
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.